Table 3.
Liver disease | miRNA signature | Expression | References |
---|---|---|---|
ALD | miR-122 (acute alcohol, microsteatosis) miR-122 and miR-155 (chronic alcohol, macrosteatosis) |
Increased Increased |
Zhang et al. (2010)126 Bala et al. (2012)12 |
NAFLD/NASH | miR-122, miRR-34a and miR-192 | Increased | Cermelli et al. (2011);118 Tryndyak et al. (2012)125 |
HCV | miR-122, miR-34a, miR-155, miR-125b, miR-146a and miR-21 | Increased | Cermelli et al. (2011);118 Bala et al. (2012);24 Zhang et al. (2012);27 Bihrer et al. (2011)32 |
HBV | miR-192 and miR-122 | Increased | Ji, et al. (2011);119 Zhang et al. (2010)126 |
Liver fibrosis/ cirrhosis |
miR-29 and miR-652 miR-513-3p and miR-571 |
Decreased Increased |
Roderburg et al. (2012);52 Roderburg et al. (2011)50 Roderburg et al. (2011)50 |
HCC | miR-21, miR-16, miR-199a, miR-122, miR-223, and miR-885-5p | Increased | Bihrer et al. (2011);32 Tomimaru et al. (2011);123 Xu et al. (2011);121 Gui et al. (2010)122 |
Drug overdose | miR-122 and miR-192 | Increased | Wang et al. (2009);76 Starkey Lewis et al. (2011);124 Bala et al. (2012)12 |
Abbreviations: ALD, alcoholic liver disease; HCC, hepatocellular carcinoma.